Italy
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.27
|
Dec. 31, 2023 | USD 103.47 | -0.44% |
|
Italy |
|
2 |
USD 1.33
|
Dec. 31, 2023 | USD 26.82 | 1.34% |
|
Italy |
|
3 |
USD 0.79
|
Dec. 31, 2023 | USD 38.13 | 0.20% |
|
Italy |
|
4 |
USD 0.55
|
Dec. 31, 2023 | USD 54.26 | 0.70% |
|
Italy |
|
5 |
USD 0.46
|
Dec. 31, 2023 | USD 4.68 | -0.92% |
|
Italy |
|
6 |
USD 0.39
|
Dec. 31, 2023 | USD 10.42 | 1.00% |
|
Italy |
|
7 |
USD 0.16
|
Dec. 31, 2023 | USD 2.04 | 0.60% |
|
Italy |
|
8 |
USD 0.07
|
Dec. 31, 2023 | USD 2.27 | -0.57% |
|
Italy |
|
9 |
USD -0.01
|
Dec. 31, 2023 | USD 7.71 | 1.97% |
|
Italy |
|
10 |
USD -0.02
|
Dec. 31, 2023 | USD 11.22 | 0.24% |
|
Italy |
|
11 |
USD -0.11
|
Dec. 31, 2023 | USD 7.37 | 1.31% |
|
Italy |
|
12 |
USD -0.13
|
Dec. 31, 2023 | USD 53.59 | 1.39% |
|
Italy |
|
13 |
USD -0.29
|
Dec. 31, 2023 | USD 19.32 | 1.97% |
|
Italy |
|
14 |
USD -0.63
|
Dec. 31, 2023 | USD 9.91 | -0.63% |
|
Italy |
|
15 |
USD -1.16
|
Dec. 31, 2023 | USD 10.47 | -1.53% |
|
Italy |
|
16 |
USD -1.40
|
Dec. 31, 2023 | USD 21.65 | -1.23% |
|
Italy |
|
17 |
USD -1.80
|
Dec. 31, 2023 | USD 4.24 | -8.82% |
|
Italy |
The Health Care company in Italy with the highest Free Cash Flow Per Share is DiaSorin S.p.A. (Milan Stock Exchange: DIA.MI) at USD 5.27.
The Health Care company in Italy with the lowest Free Cash Flow Per Share is Genenta Science S.p.A. (NasdaqCM: GNTA) at USD -1.80.
The top 10 Health Care companies in Italy by Free Cash Flow Per Share are DiaSorin S.p.A., Amplifon S.p.A., SOL S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., GVS S.p.A., Technogym S.p.A., ARTERRA BIOSCIENCE, Media Lab S.p.A., Fine Foods & Pharmaceuticals N.T.M. S.p.A. and EL.En. S.p.A..
The bottom 10 Health Care companies in Italy by Free Cash Flow Per Share are Genenta Science S.p.A., Stevanato Group S.p.A., GPI S.p.A., Newron Pharmaceuticals S.p.A., Philogen S.p.A., Pharmanutra S.p.A., Franchetti S.p.A., EL.En. S.p.A., Fine Foods & Pharmaceuticals N.T.M. S.p.A. and Media Lab S.p.A..